ABOUT 9th_IOIF
> ATTENDEES
> INVESTORS
​​> PRESENTERS
​​> SPONSORS
​> SUPPORTERS

3B Future Health Ventures
3i Fund
3i Partners (Impact India Investment Partners)
6 Dimensions Capital
AbbVie, Inc.
adMare BioInnovations
Affimed N.V.
AgonOx, Inc.
Aleta Biotherapeutics
Alloy Therapeutics, Inc.
Alpha Bronze
ALSA Ventures
Aqua Partners LLC
Ardan Pharma USA, INC.
Astellas Pharma, Inc.
Astellas Venture Management LLC
AstraZeneca
Athos Group
AVANTECA Partners AG
Avstera Therapeutics Corp.
BERNINA BioInvest Ltd.
Bio Med Gene Ventures
BioNTech SE
Bioqube Ventures
BIOSTART Consulting GmbH
Black Diamond Therapeutics
BOHE Angel Fund
Bpifrance
Breslin AG
BrightEdge, LLC
BTIG, LLC
Cambrian Capital
Carina Biotech
Catalym GmbH
Catalytic Impact Foundation
CCRM Enterprises
CharaBio
Codagenix Inc.
CSPC Pharmaceutical Group Limited
Cytovation ASA
Cytovia Therapeutics, Inc.
Deca Ventures, LLC
DFB Pharmaceuticals, LLC
EcoR1 Capital, LLC
Edison Group
Elpiscience Biopharma
EMD Serono, Inc.
Enterome S.A.
ESC Advisors
EXUMA Biotechnology
Foghorn Therapeutics
Fraser Finance LLP
FreeMind Group
Geneos Therapeutics, Inc.
Generation Fund Life Sciences Fund I
GlaxoSmithKline
Globescape Capital Inc
GLSV GmbH iL, MicroCures Inc, Neurevo GmbH
Gritstone bio, Inc.
H.C. Wainwright
Harbour BioMed
HealthCare Royalty Partners
Hinge Bio, Inc.
Iaso Ventures
ICF Consult Switzerland
ICR Westwicke
IGM Biosciences
Immunophotonics, Inc.
Indaco Bio Fund
Indaco Venture Partners SGR S.p.A.
Independent KT.M.
IPF Management S.A.
ISA Pharmaceuticals B.V.
JL Biopharma Consulting LLC
Johnson & Johnson Innovation LLC
KinaRx, Inc

KLUS Pharma
L.E.K. Consulting
LanceBio Ventures
Landmark Family Office/Landmark Angels
Larkspur Biosciences, Inc.
Lazard Ltd.
Leukemia & Lymphoma Society
Loncar Investments, LLC
Lumanity
Lumira Ventures
MAIA Biotechnology, Inc.
Mayo Clinic
Mediqventures
MEDiSTRAVA Consulting
Merck Group
Merck KGaA, Darmstadt, Germany
Merck Serono
Mianus Capital
Momentum Biotech
MorphoSys AG
MPM Capital, Inc.
MSQ Ventures
Nammi Therapeutics, Inc.
NanOlogy LLC
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Navrogen, Inc.
New Science Fund
Nouscom AG
Novartis AG
Novatio Ventures
NxR Biotechnologies GmbH
Omega Funds
ONO Pharmaceuticals USA
Oppenheimer & Co. Inc.
Orange Grove Bio
Orna Therapeutics, Inc.
Panakès Partners SGR S.p.A.
Pfizer, Inc.
Prevail Partners LLC
Promontory Therapeutics Inc.
Pyramid Bio
QBiotics Group Limited
Quan Capital
RA Capital Management, L.P.
RAPT Therapeutics, Inc.
RenovoRx, Inc.
RSJ Investments
Salus Partners SA
Sangel Capital Corp.
Scorpion Therapeutics
Sensius B.V.
Silicon Valley Bank: A Division of First Citizens Bank
Sixty Degree Capital
SternAegis Ventures
Strand Therapeutics
SVB Securities
Syno Capital
Tactical Therapeutics, Inc.
Taiho Ventures, LLC
TAL Ventures LLC
Tessera Therapeutics
The Leukemia & Lymphoma Society
TPG Life Sciences Innovations
Transgene SA
Triumvira Immunologics, Inc.
Tyligand Bioscience
Ultimovacs ASA
Vogel BioC
VU Venture Partners
Vyriad, Inc.
WA4STEAM
WallachBeth Capital
Wellington Partners
Wille Finance AG
Zai Lab Ltd.

Last updated on: 2nd of June